Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
Search content at Universidad de los Andes
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
Initial results with [
18
F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis
Yuriko Mori
*
, Vasko Kramer
, Emil Novruzov
, Eduards Mamlins
, Manuel Röhrich
, René Fernández
, Horacio Amaral
, Cristian Soza-Ried
, Barbara Monje
, Eduardo Sabbagh
, Matías Florenzano
, Frederik L. Giesel
, Álvaro Undurraga
*
Corresponding author for this work
Clínica Universidad de los Andes
Universidad de los Andes
Research output
:
Contribution to journal
›
Article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Initial results with [
18
F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Idiopathic Pulmonary Fibrosis
100%
18F-FAPI
100%
Positron Emission Tomography/computed Tomography (PET/CT)
100%
Lung
25%
Imaging Results
25%
Economic Benefits
25%
Fibrosis
25%
Clinical Parameters
25%
Poor Prognosis
25%
Non-invasive Assessment
25%
Patient Cohort
25%
Radiological Parameters
25%
Large-scale Production
25%
PET Scan
25%
Fibrotic Changes
25%
Pulmonary Disease
25%
Small Patients
25%
Active Volume
25%
Lung Diffusing Capacity
25%
18F-labeled
25%
Hounsfield Scale
25%
Fibrosis Imaging
25%
Lung Area
25%
Activated Fibroblasts
25%
Vital Capacity
25%
Assessment Methods
25%
Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
25%
Tracer Uptake
25%
68Ga-labeling
25%
HRCT Scans
25%
Medicine and Dentistry
Fluorine-18
100%
Positron Emission Tomography-Computed Tomography
100%
Idiopathic Pulmonary Fibrosis
100%
Lung
60%
Silo-Filler's Disease
20%
Fibrosis
20%
Radioactive Tracer
20%
Fibroblast
20%
Hounsfield Scale
20%
Interstitial Lung Disease
20%
Diffusing Capacity
20%
Gallium 68
20%
Pharmacology, Toxicology and Pharmaceutical Science
Fluorine 18
100%
Polyethylene Terephthalate
100%
Fibrosing Alveolitis
100%
Lung Disease
20%
Tracer
20%
Fibrosis
20%
Gallium 68
20%
Interstitial Lung Disease
20%